| 2026-07-28 | Deck | Corporate Presentation – July 2026 |
| 2026-07-28 | Deck | Kiniksa Pharmaceuticals Second Quarter 2026 Earnings Conference Call |
| 2026-07-28 | Press release | Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution |
| 2026-07-28 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-28 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-28 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-28 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-23 | Press release | Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on |
| 2026-05-29 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-26 | 8-K | Form 8-K, Item 1.01 |
| 2026-05-01 | 8-K | Form 8-K, Item 5.02 |
| 2026-04-28 | Deck | First Quarter 2026 Financial Results and Recent Portfolio Execution |
| 2026-04-28 | Press release | Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution |
| 2026-04-28 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-28 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-23 | Press release | Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 |
| 2026-04-16 | Proxy | Definitive proxy statement |
| 2026-02-24 | Press release | Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution |
| 2026-02-24 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-24 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-24 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-19 | Press release | Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on |
| 2026-01-14 | 8-K | Form 8-K, Item 5.02 |
| 2026-01-12 | 8-K | Form 8-K, Item 2.02 results |
| 2025-10-28 | Press release | Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution |
| 2025-10-28 | 8-K | Form 8-K, Item 2.02 results |
| 2025-10-28 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-23 | Press release | Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025 |
| 2025-09-03 | 8-K | Form 8-K, Item 7.01 |
| 2025-07-29 | Press release | Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution |
| 2025-07-29 | 8-K | Form 8-K, Item 2.02 results |
| 2025-07-29 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-07-24 | Press release | Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 |
| 2025-06-05 | 8-K | Form 8-K, Item 7.01 |
| 2025-06-03 | 8-K | Form 8-K, Item 5.07 |
| 2025-04-29 | Press release | Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution |
| 2025-04-29 | 8-K | Form 8-K, Item 2.02 results |
| 2025-04-29 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2025-04-24 | Press release | Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025 |
| 2025-04-23 | 8-K | Form 8-K, Item 5.02 |